So Flemming is an asshole. Narcissistic, self-centered and abrasive personality.
But, H1 results are impressive.
Double digits in aesthetics and skincare is a solid result.
US performance is piss poorSo Flemming is an asshole. Narcissistic, self-centered and abrasive personality.
But, H1 results are impressive.
Double digits in aesthetics and skincare is a solid result.
Exactly. 100% support this.i hope this copany crashes and burns and all the people who have mae others suffer - Flemming, David Cox, Shires, AL, CM, EB, PD who have lied and have been duplicitous feel the pain
Flemming will soon start replacing US leadership. He cannot afford to have an underperforming US unit, especially not ahead of nemolizumab launch.The dumbass who started this thread doesnt understand that double digit growht means nothing if what they had promised to the street in order to IPO to go well was more than that. US team sucks - we have been saying that for a while. double digit growth on current small markets like china, india etc means nothing. US doesnt perform we are screwed. Also, Q2 is artificially inflated in the US based on all the "phasing" we do for Q2. no way we make Q3 and Q4. Congrats to the US leadership team for driving a 5% decline in stock price.
International markets are now 55% of sales. Not long ago the US was that percentage….no surprise reps are not having bonuses paid out. The US needs to perform better.The dumbass who started this thread doesnt understand that double digit growht means nothing if what they had promised to the street in order to IPO to go well was more than that. US team sucks - we have been saying that for a while. double digit growth on current small markets like china, india etc means nothing. US doesnt perform we are screwed. Also, Q2 is artificially inflated in the US based on all the "phasing" we do for Q2. no way we make Q3 and Q4. Congrats to the US leadership team for driving a 5% decline in stock price.
Same here. Really hate Galderma and more so Flemming.Hate Galderma with passion - omg these people are liars like no other
lol. Need to change US leaders and cut fat.How hard Flemming gets is related to the stock price. It is so obvious from his shitty speech on H1 results that they are trying to paint the entire pig with lipsticks and call it a unicorn. Well guess what assholes thw day of reckoning might actually be here. When you screw up Nemo launch that would be the nail in the coffin. Hope all leaders at Galderma suffer. And to all the other assholes who were hoping the stock price owls remain high and they would sell at 6 month mark and bounce tough luck you’re stuck eating the the byproducts of the human centipede.
I am on the global teams and the chatter and word has already started. US colleagues need to pull their weight. I have seen some of their salaries compared to European counterparts and it’s crazy they don’t produce and earn more. Time to cut some folks.lol. Need to change US leaders and cut fat.
4.5% US growth…you shitting me? lol. JPAC is a 10th of the cost and 3 time more productive. Starts with leads and marketers you jackass. Read all around car pharma US leadership sucks nads. Priorities are all wrong and it’s patchwork through and through. Can’t wait for this ship to sink in Q3 and Q4. This was supposed to be the “gimme” quarter with everything phases up to Q2. Galderma is really fed now. Enjoy your 2 bit position while it lasts. I am applying and have some good offers - so eat shit galderma. You’ll see my resignation in a couple weeks.All of you entry level people and sales reps should be thankful for a job. US is doing poorly? It’s because of you, your bad attitudes, and crap performance. Step up and do your job and we will get the US to do better! Lazy, entitled, ungrateful!!!
